Catalyst Pharmaceuticals (CPRX) Short-term Investments (2011 - 2022)

Catalyst Pharmaceuticals' Short-term Investments history runs 12 years deep, the most recent figure standing at $9.9 million for Q2 2022.

• Quarterly Short-term Investments fell 50.57% year-over-year to $9.9 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $9.9 million (down 50.57% YoY) and the FY2021 annual result came in at $19.8 million, up 97.4% from the prior year.
• Short-term Investments was $9.9 million for Q2 2022 at Catalyst Pharmaceuticals, down from $19.4 million in the prior quarter.
• Across five years, Short-term Investments topped out at $58.5 million in Q2 2018 and bottomed at $5.0 million in Q4 2019.
• A 5-year average of $26.8 million and a median of $20.0 million in 2021 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2018 — Short-term Investments jumped 120.44% — and 2019, when it slumped 86.44%.
• Catalyst Pharmaceuticals' Short-term Investments stood at $36.9 million in 2018, then slumped by 86.44% to $5.0 million in 2019, then soared by 100.54% to $10.0 million in 2020, then jumped by 97.4% to $19.8 million in 2021, then sank by 50.17% to $9.9 million in 2022.
• Business Quant data shows CPRX's Short-term Investments at $9.9 million in Q2 2022, $19.4 million in Q1 2022, and $19.8 million in Q4 2021.